Biogen Shows Off More Positive Alzheimer???s Trial Data Post author:Sam Post published:August 27, 2017 Post category:BioPharma August 28, 2017By Mark Terry, BioSpace.com Breaking News StaffCambridge, Mass… Source: BioSpace You Might Also Like It's Confirmed: Celgene's Former CEO and Chairman is Making a Run for the Senate February 12, 2018 Cambridge Startup Inozyme Nabs $49M and a Roster Packed With Seasoned Vets November 14, 2017 Envisia Therapeutics Releases Interim ENV515 (Travoprost XR) Phase II Data Demonstrating 11-Month Duration-Of-Action After A Single Dose In Patients With Glaucoma February 2, 2017
Envisia Therapeutics Releases Interim ENV515 (Travoprost XR) Phase II Data Demonstrating 11-Month Duration-Of-Action After A Single Dose In Patients With Glaucoma February 2, 2017
